Lapatinib clinical trial update
9 September 2011 | By GSK
A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb®), trastuzumab, has resulted in a change to the ongoing study...
List view / Grid view
9 September 2011 | By GSK
A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb®), trastuzumab, has resulted in a change to the ongoing study...
8 September 2011 | By Abbott
Abbott announced the initiation of ABSORB BTK...
8 September 2011 | By PerkinElmer
PerkinElmer, Inc. has signed a definitive agreement to acquire Caliper Life Sciences, Inc...
8 September 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc...
8 September 2011 | By Roche
Roche recognized as the most sustainable healthcare company globally in the DJSI...
8 September 2011 | By Novartis
The European Commission has approved Votubia® (everolimus) tablets* for the treatment of patients aged 3 years and older...
7 September 2011 | By GSK
Jens Eckstein has been named President of SR One, GSK’s independent healthcare venture organisation, effective 1 October...
7 September 2011 | By Boehringer Ingelheim
Boehringer Ingelheim wins the '2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award'...
6 September 2011 | By Biogen Idec
Biogen Idec will acquire 100% of Dompé shares in its joint ventures in both Italy and Switzerland...
6 September 2011 | By Bayer
Study to be reviewed by the FDA Cardiovascular and Renal Drugs Advisory Committee...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced that Dr. Alexander Makarov, its director of global research for life sciences mass spectrometry, has received the first HUPO Science and Technology Award from the Human Proteome Organization (HUPO).
6 September 2011 | By Pfizer
Pfizer and Icagen announced the successful completion of the initial cash tender offer...
6 September 2011 | By GSK
GSK & the BARDA have agreed to a contract that will support the development by GSK of a potentially new antibiotic against both hospital Gram negative & biothreat pathogens...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced at the Human Proteome Organization (HUPO) 2011 World Congress the establishment of a new Biomarker Translational Center (BT Center).
6 September 2011 | By Evotec AG
Evotec's MAO-B inhibitor in patients with Alzheimer's disease (AD) to be developed...